BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rouse R, Xu L, Stewart S, Zhang J. High fat diet and GLP-1 drugs induce pancreatic injury in mice. Toxicol Appl Pharmacol. 2014;276:104-114. [PMID: 24534256 DOI: 10.1016/j.taap.2014.01.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Akalestou E, Christakis I, Solomou AM, Minnion JS, Rutter GA, Bloom SR. Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats. Pancreas 2016;45:967-73. [PMID: 26731187 DOI: 10.1097/MPA.0000000000000585] [Reference Citation Analysis]
2 Vahle JL, Byrd RA, Blackbourne JL, Martin JA, Sorden SD, Ryan T, Pienkowski T, Rosol TJ, Snyder PW, Klöppel G. Effects of the GLP-1 Receptor Agonist Dulaglutide on the Structure of the Exocrine Pancreas of Cynomolgus Monkeys. Toxicol Pathol 2015;43:1004-14. [PMID: 26059826 DOI: 10.1177/0192623315588999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Rouse R, Zhang L, Shea K, Zhou H, Xu L, Stewart S, Rosenzweig B, Zhang J. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet. PLoS One 2014;9:e109477. [PMID: 25291183 DOI: 10.1371/journal.pone.0109477] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
4 Ni Z, Zhang Y, Wang H, Wei Y, Ma B, Hao J, Tu P, Duan H, Li X, Jiang P, Ma X, Wang B, Wu R, Zhu J, Li M. Construction of a Fusion Peptide 5rolGLP-HV and Analysis of its Therapeutic Effect on Type 2 Diabetes Mellitus and Thrombosis in Mice. Appl Biochem Biotechnol 2016;179:59-74. [DOI: 10.1007/s12010-016-1979-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Filippatos TD, Panagiotopoulou TV, Elisaf MS. Adverse Effects of GLP-1 Receptor Agonists. Rev Diabet Stud 2014;11:202-30. [PMID: 26177483 DOI: 10.1900/RDS.2014.11.202] [Cited by in Crossref: 79] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
6 Williams JA. GLP-1 mimetic drugs and the risk of exocrine pancreatic disease: Cell and animal studies. Pancreatology 2016;16:2-7. [DOI: 10.1016/j.pan.2015.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Haluzík M, Mráz M, Svačina Š. Balancing benefits and risks in patients receiving incretin-based therapies: focus on cardiovascular and pancreatic side effects. Drug Saf 2014;37:1003-10. [PMID: 25391858 DOI: 10.1007/s40264-014-0238-8] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
8 Owolabi BO, Ojo OO, Srinivasan DK, Conlon JM, Flatt PR, Abdel-wahab YHA. Glucoregulatory, endocrine and morphological effects of [P5K]hymenochirin-1B in mice with diet-induced glucose intolerance and insulin resistance. Naunyn-Schmiedeberg's Arch Pharmacol 2016;389:769-81. [DOI: 10.1007/s00210-016-1243-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ercan G, Ilbar Tartar R, Solmaz A, Gulcicek OB, Karagulle OO, Meric S, Cayoren H, Kusaslan R, Kemik A, Gokceoglu Kayali D, Cetinel S, Celik A. Examination of protective and therapeutic effects of ruscogenin on cerulein-induced experimental acute pancreatitis in rats. Ann Surg Treat Res. 2019;97:271-281. [PMID: 31824881 DOI: 10.4174/astr.2019.97.6.271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Arden C. A role for Glucagon-Like Peptide-1 in the regulation of β-cell autophagy. Peptides 2018;100:85-93. [PMID: 29412836 DOI: 10.1016/j.peptides.2017.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
11 He L, Zhang S, Zhang X, Liu R, Guan H, Zhang H. Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer. Onco Targets Ther 2017;10:5621-31. [PMID: 29200876 DOI: 10.2147/OTT.S150701] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Ja'arah D, Al Zoubi MS, Abdelhady G, Rabi F, Tambuwala MM. Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia. Clin Med Insights Endocrinol Diabetes 2021;14:11795514211051697. [PMID: 34690504 DOI: 10.1177/11795514211051697] [Reference Citation Analysis]
13 Zhou B, Ji K, Peng A, Yang X, Huang K. GLP-1(28-36)amide, a Long Ignored Peptide Revisited. Open Biochem J 2014;8:107-11. [PMID: 25598850 DOI: 10.2174/1874091X01408010107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
14 Saloman JL, Albers KM, Cruz-Monserrate Z, Davis BM, Edderkaoui M, Eibl G, Epouhe AY, Gedeon JY, Gorelick FS, Grippo PJ, Groblewski GE, Husain SZ, Lai KKY, Pandol SJ, Uc A, Wen L, Whitcomb DC. Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer. Pancreas 2019;48:759-79. [PMID: 31206467 DOI: 10.1097/MPA.0000000000001335] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
15 Pathak R, Kumar A, Palfrey HA, Forney LA, Stone KP, Raju NR, Gettys TW, Murthy SN. The incretin enhancer, sitagliptin, exacerbates expression of hepatic inflammatory markers in rats fed a high-cholesterol diet. Inflamm Res 2019;68:581-95. [PMID: 31073849 DOI: 10.1007/s00011-019-01243-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Hua F, Yu JJ, Hu ZW. Diabetes and cancer, common threads and missing links. Cancer Lett 2016;374:54-61. [PMID: 26879686 DOI: 10.1016/j.canlet.2016.02.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
17 O'Harte FP, Ng MT, Lynch AM, Conlon JM, Flatt PR. Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice. Diabetes Obes Metab 2016;18:1013-24. [PMID: 27357054 DOI: 10.1111/dom.12713] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
18 El-Megharbel SM, Refat MS, Al-Salmi FA, Hamza RZ. In Situ Neutral System Synthesis, Spectroscopic, and Biological Interpretations of Magnesium(II), Calcium(II), Chromium(III), Zinc(II), Copper(II) and Selenium(IV) Sitagliptin Complexes. Int J Environ Res Public Health 2021;18:8030. [PMID: 34360322 DOI: 10.3390/ijerph18158030] [Reference Citation Analysis]
19 Ni Z, Wang B, Ma X, Duan H, Jiang P, Li X, Wei Q, Ji X, Li M. Toxicology Assessment of a Dual-Function Peptide 5rolGLP-HV in Mice. Appl Biochem Biotechnol 2016;180:1276-85. [DOI: 10.1007/s12010-016-2166-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Cox AR, Lam CJ, Rankin MM, Rios JS, Chavez J, Bonnyman CW, King KB, Wells RA, Anthony D, Tu JX, Kim JJ, Li C, Kushner JA. Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male Mice. Endocrinology 2017;158:1701-14. [PMID: 28323942 DOI: 10.1210/en.2017-00027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
21 Shawky LM, Morsi AA, El Bana E, Hanafy SM. The Biological Impacts of Sitagliptin on the Pancreas of a Rat Model of Type 2 Diabetes Mellitus: Drug Interactions with Metformin. Biology (Basel) 2019;9:E6. [PMID: 31881657 DOI: 10.3390/biology9010006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
22 Weissman S, Aziz M, Perumpail RB, Mehta TI, Patel R, Tabibian JH. Ever-increasing diversity of drug-induced pancreatitis. World J Gastroenterol 2020; 26(22): 2902-2915 [PMID: 32587438 DOI: 10.3748/wjg.v26.i22.2902] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
23 Kumar A, Pathak R, Palfrey HA, Stone KP, Gettys TW, Murthy SN. High levels of dietary methionine improves sitagliptin-induced hepatotoxicity by attenuating oxidative stress in hypercholesterolemic rats. Nutr Metab (Lond) 2020;17:2. [PMID: 31921324 DOI: 10.1186/s12986-019-0422-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]